Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lexington, KY
NPI
1073721700
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
740 S Limestone St, Endocrine Clinic, 2nd Floor, Wing C
Lexington, KY, 40536
Phone (859) 323-2232
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
699 services
Medicare patients, 2024
157
Average age 71
Drug cost, 2024
$1.5M
3,467 prescriptions
Company payments, 2025
$77.13
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megha Desai was code 99214 (office e&m - established), 159 times for 94 patients. In total Megha Desai billed 699 services in 12 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 159 | 94 | $88.97 | $14K |
| 36415 Venipuncture Blood Collection | Office | 146 | 103 | $8.59 | $1,255 |
| 83036 Blood Count | Office | 113 | 68 | $9.44 | $1,066 |
| 82947 Clinical Chemistry | Office | 97 | 54 | $3.77 | $366 |
| 99213 Office E&M - Established | Office | 83 | 68 | $61.88 | $5,136 |
| 95251 Test - Miscellaneous | Office | 51 | 26 | $26.64 | $1,359 |
| 99204 Office E&M - New | Office | 21 | 21 | $117.72 | $2,472 |
| 76536 Ultrasound - Nonspecific | Office | 14 | 13 | $77.29 | $1,082 |
By year: 2022 $22K for 537 services; 2023 $22K for 561 services; 2024 $28K for 699 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 146 | 103 | $8.59 | $1,255 |
| 83036 Blood Count | 113 | 68 | $9.44 | $1,066 |
| 82947 Clinical Chemistry | 97 | 54 | $3.77 | $366 |
Medicare prescription drug claims, 2024
In 2024, the drug Megha Desai prescribed most often to Medicare patients was Levothyroxine Sodium, with 327 prescriptions and refills. In total Megha Desai wrote 3,467 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 327 | 865 | 94 | $3,756 |
| Metformin Hcl Er Metformin Hcl | 315 | 799 | 88 | $2,126 |
| Mounjaro Tirzepatide | 304 | 371 | 50 | $383K |
| Ozempic Semaglutide | 162 | 211 | 33 | $199K |
| Gabapentin Generic | 122 | 156 | 24 | $1,217 |
| Jardiance Empagliflozin | 119 | 241 | 33 | $138K |
| Synthroid Levothyroxine Sodium | 108 | 276 | 33 | $6,000 |
| Glimepiride Generic | 89 | 237 | 34 | $688 |
| Atorvastatin Calcium Generic | 79 | 211 | 25 | $580 |
| Tresiba Flextouch U-100 Insulin Degludec | 63 | 106 | 18 | $43K |
| Metformin Hcl Generic | 63 | 187 | 25 | $351 |
| Trulicity Dulaglutide | 57 | 102 | 18 | $99K |
| Methimazole Generic | 51 | 101 | 18 | $494 |
| Tresiba Flextouch U-200 Insulin Degludec | 50 | 80 | 17 | $58K |
| Novolog Flexpen Insulin Aspart | 50 | 85 | 21 | $11K |
Brand drugs: 1,832 claims; generic drugs: 1,440 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megha Desai $77.13 ($77.13 in general payments such as food, travel and fees) from 4 companies. The largest payer was Neurocrine BioSciences, Inc. with $20.94.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.